Marsh, Munich Re & Metabiota launch parametric pandemic insurance

Global broker and risk consultancy Marsh has launched PathogenRX, an insurance product designed to protect businesses against pandemic risks such as the outbreak of infectious diseases, that utilises a parametric trigger provided by epidemic risk modeling specialists Metabiota and capacity from reinsurance giant Munich Re.The impact of infectious disease outbreaks read the full article →

ARC and Metabiota begin parametric outbreak & epidemic insurance pilot

The African Risk Capacity (ARC), a parametric sovereign disaster risk insurer for African nations, has begun a pilot with the help of San Francisco based Metabiota to roll-out parametric insurance cover against disease outbreaks and epidemics.The new parametric outbreak & epidemic insurance product has been coming for some time, as ARC read the full article →

Parametric outbreak & epidemic insurance launched by ARC

The African Risk Capacity (ARC), the provider of parametric sovereign disaster risk insurance and other support to African nations, has launched a new insurance product designed to cover disease outbreaks and epidemics.The outbreak and epidemic parametric insurance product has been designed to deliver rapid payouts and targeted funds for detected read the full article →

Metabiota launches epidemic risk modeling platform & index

San Francisco based Metabiota, a company focused on risk analytics for epidemics, has launched its first commercial risk modelling platform and a preparedness index to help insurance or reinsurance firms and ILS funds or investors understand and underwrite epidemic risk.In announcing the launch today Metabiota said that it has signed read the full article →

Swiss Re in Vita Capital V mortality cat bond early redemption

Global reinsurance firm Swiss Re has continued its trend of redeeming its series of Vita Capital mortality linked catastrophe bonds, with its $275m 2012 transaction Vita Capital V Ltd. called a year early and investors to be paid a premium of 1%.Swiss Re has regularly redeemed its mortality catastrophe bonds read the full article →

Metabiota provides risk analytics for epidemic risk transfer products

San Francisco based Metabiota, a company focused on risk analytics for epidemic, is working with reinsurance and insurance companies to create risk transfer and financing solutions that can provide epidemic or outbreak insurance.Metabiota is interesting as they assist with the understanding of epidemic outbreaks and spread, crucial to those insurance read the full article →

Vita Capital V takes Swiss Re’s Vita extreme mortality protection to over $2.25 billion

Reinsurer Swiss Re has released some comments on the completion of their latest extreme mortality securitization, Vita Capital V Ltd. As we wrote earlier today, Vita Capital V successfully completed at $275m yesterday and received its ratings. It's Swiss Re's fifth Vita securitization in the last three years and the read the full article →

Vita Capital V Ltd. completes successfully, takes 2012 insurance-linked securities issuance to $4 billion

Swiss Re's sixth issuance in their series of Vita mortality-linked catastrophe bond (or insurance-linked security) deals has completed successfully. Vita Capital V Ltd. completed and received its formal ratings yesterday after being in the market since we first wrote about the deal three weeks ago, during which time it nearly read the full article →

Swiss Re’s Vita Capital V mortality-linked catastrophe bond upsizes significantly

As we wrote recently, Swiss Re are marketing the sixth issuance in their series of Vita mortality-linked catastrophe bond (or insurance-linked security) deals. The transaction, Vita Capital V Ltd. , which has been marketing for two weeks began as a $100m deal split into two tranches of mortality-linked notes according read the full article →

Vita Capital V Ltd. marketing, new mortality-linked catastrophe bond from Swiss Re

Reinsurer Swiss Re has begun marketing their latest insurance-linked security transaction and this time it's a deal that the wider ILS investment market should appreciate as it's a diversifying opportunity and a life transaction. Swiss Re are bringing their latest Vita Capital mortality-linked catastrophe bond to market, their fifth such read the full article →